Hepatitis C is associated with an increased risk of chronic kidney disease (CKD). Treating hep C may reduce this risk. Although medications in general can be hard on the kidneys, most of the drugs used to treat hepatitis C are safe.
The decision of which drugs to use is based on genotype and the stage of your kidney disease. Zepatier or Mavyret are recommended for people with advanced CKD. Most, but not all of the remaining drugs may used for earlier stages of CKD. Click here to read about recommended hepatitis C treatment for people with renal impairment. Treatment recommendations for kidney transplant patients is available here.
March is National Kidney Month. Here is a link to general information about kidney disease.